Loading
AP
Anadys Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by QVT Associates GP LLC, was filed 05 Jan 2011.
Anadys Pharmaceuticals Inc: what insiders have been doing
Every trade that managers of Anadys Pharmaceuticals Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Anadys Pharmaceuticals Inc in twelve months, the latest record being from 24 October 2011.
The full history, which starts in 2006, counts 76 purchases against 120 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
210
Thresholds
n/a
Buy Volume
€7M
76 ops. · all time
Sell Volume
€19M
120 ops. · all time
Last declaration on 24 October 2011
Declarations210 total
5,252,700 shares@ US$3.68Common Stock, $0.001 par valueSEC:0001209191-11-052489:0
364,918 shares@ US$3.68Common Stock, $0.001 par valueSEC:0001209191-11-052489:1
650,100 shares@ US$3.68Common Stock, $0.001 par valueSEC:0001209191-11-052181:0
34,209 shares@ US$1.41Common Stock, $0.001 par valueSEC:0001181431-11-002006:0
Canonical exit: 3 Apr 2011 (T+90)
50,000 shares@ US$1.46Common Stock, $0.001 par valueSEC:0001181431-11-000429:0
Canonical exit: 29 Mar 2011 (T+90)
267,014 shares@ US$1.45Common Stock, $0.001 par valueSEC:0001181431-11-000429:1
Canonical exit: 29 Mar 2011 (T+90)
300 shares@ US$1.48Common Stock, $0.001 par valueSEC:0001181431-11-000429:2
Canonical exit: 30 Mar 2011 (T+90)
1,714,210 shares@ US$1.30Common Stock, $0.001 par valueSEC:0001181431-10-064096:0
Canonical exit: 27 Mar 2011 (T+90)
12,200 shares@ US$1.34Common Stock, $0.001 par valueSEC:0001181431-10-064096:1
Canonical exit: 28 Mar 2011 (T+90)
532,490 shares@ US$1.44Common Stock, $0.001 par valueSEC:0001181431-10-064096:2
Canonical exit: 28 Mar 2011 (T+90)
285,790 shares@ US$1.21Common Stock, $0.001 par valueSEC:0001181431-10-063627:0
Canonical exit: 23 Mar 2011 (T+90)
150,000 shares@ US$1.65Common Stock, $0.001 par valueSEC:0001181431-10-051764:0
Canonical exit: 18 Jan 2011 (T+90)
1,951,389 shares@ US$1.80Common Stock, $0.001 par valueSEC:0001181431-10-051388:0
Canonical exit: 13 Jan 2011 (T+90)
90,000 shares@ US$1.68Common Stock, $0.001 par valueSEC:0001181431-10-051388:1
Canonical exit: 13 Jan 2011 (T+90)
25,000 shares@ US$1.67Common Stock, $0.001 par valueSEC:0001181431-10-051388:2
Canonical exit: 13 Jan 2011 (T+90)
85,000 shares@ US$1.66Common Stock, $0.001 par valueSEC:0001181431-10-051388:3
Canonical exit: 13 Jan 2011 (T+90)
150,000 shares@ US$1.65Common Stock, $0.001 par valueSEC:0001181431-10-051388:4
Canonical exit: 13 Jan 2011 (T+90)
8,000 shares@ US$1.78Common Stock, $0.001 par valueSEC:0001181431-10-047373:0
Canonical exit: 15 Dec 2010 (T+90)
25,000 shares@ US$1.80Common Stock, $0.001 par valueSEC:0001181431-10-046635:0
Canonical exit: 9 Dec 2010 (T+90)
25,000 shares@ US$1.74Common Stock, $0.001 par valueSEC:0001181431-10-045633:0
Canonical exit: 30 Nov 2010 (T+90)
6,000 shares@ US$1.75Common Stock, $0.001 par valueSEC:0001181431-10-044955:0
Canonical exit: 25 Nov 2010 (T+90)
25,000 shares@ US$1.77Common Stock, $0.001 par valueSEC:0001181431-10-044955:1
Canonical exit: 28 Nov 2010 (T+90)
17,400 shares@ US$1.70Common Stock, $0.001 par valueSEC:0001181431-10-044660:0
Canonical exit: 23 Nov 2010 (T+90)
15,700 shares@ US$1.75Common Stock, $0.001 par valueSEC:0001181431-10-044660:1
Canonical exit: 24 Nov 2010 (T+90)
27,000 shares@ US$1.79Common Stock, $0.001 par valueSEC:0001181431-10-044156:0
Canonical exit: 21 Nov 2010 (T+90)
25 of 210 declarations
